Acurx Pharmaceuticals, Inc. (ACXP) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $2.42M | -25.3% |
| 2024 | $3.24M | +6.6% |
| 2023 | $3.04M | +47.6% |
| 2022 | $2.06M | +144.3% |
| 2021 | $843.9K | +61.5% |
| 2020 | $522.4K | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $2.42M | -25.3% |
| 2024 | $3.24M | +6.6% |
| 2023 | $3.04M | +47.6% |
| 2022 | $2.06M | +144.3% |
| 2021 | $843.9K | +61.5% |
| 2020 | $522.4K | — |